Icon

KERYDIN (nda204427)- (5%)

TAVABOROLE ANACOR PHARMS INC
5%
Yes No
2027-Nov-26 2019-Jul-07
None None
None No
KERYDIN is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
9 0 9
Total Other Developers 10
Drugs with Suitability No
5% ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ******** ******* ******* *********** **** ** *-* ******* ********** ******, *****, ******, ***** (***) ***
****** ****** ****** ******** ******* ******* *********** **** **, ********* ********** ******, *****, ******* ****,, ******, *********** ******, ***** (***) ***
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** ***** ********, **** ** ***/* *** ***/*, ********, ******* ******, ***** (***) ***
****** **** **** *************** ***. *********** *** **** *****, ********, ******* *** ***, ****** (***) ***
****** ***** ****** ******** ******* ******* *********** **** ** *-* ******* ********** ******, *****, ******, ***** (***) ***
****** ***** ***** ******** ***** ******* ******* *** *********** **** **: **/*, *.*.****** ****, ******** ******,, **********, ****** ******* ******, ***** (***) ***
****** ****** ****** ***************, *** *********** *** ******** ***** ** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **.***-***, *******-***** ******** ******* **. ** *********, ***-******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.